MedTrace Logo

Sildenafil Citrate of in Vitro Fertilization After Multiple IVF Failures Attributed to Poor Endometrial Development

NCT03044561 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-02-07

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of sildenafil citrate on endometrial development in women with history of recurrent implantation failure after IVF

Conditions

  • IVF Failure

Interventions

DRUG

Sildenafil Citrate

25 mg orally, 4 times per day for 21 days

DRUG

matching placebo

orally, 4 times per day for 21 days

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • ahmed khairy, professor · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-08-01
Completion
2017-08-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03044561 on ClinicalTrials.gov